Hypertension, Cause of: Pheochromocytoma Explained
Table of Contents
Introduction
Pheochromocytoma is a rare neuroendocrine tumor that develops in the adrenal glands. This tumor secretes excessive amounts of catecholamines, leading to a variety of symptoms, most notably hypertension. Pheochromocytoma is a significant cause of secondary hypertension, accounting for 0.1-0.6% of all cases. [1]
Epidemiology
The prevalence of pheochromocytoma is estimated to be 1 in 2,500 to 6,500 individuals with hypertension. [1] Pheochromocytomas can occur at any age but are most common in the fourth to fifth decade of life. They affect both sexes equally and can be sporadic or familial.
Pathophysiology
Pheochromocytomas originate from chromaffin cells in the adrenal medulla. These tumors secrete excessive amounts of catecholamines, primarily norepinephrine and epinephrine, leading to sustained hypertension. The high levels of plasma norepinephrine correlate with the severity of hypertension. [2]
Clinical Features
The most common symptoms of pheochromocytoma include:
- High blood pressure (hypertension)
- Headache
- Excessive sweating
- Palpitations (pounding, fast, or irregular heartbeat)
- Shakiness
Patients may experience acute hypertensive crises, which can lead to life-threatening complications such as hypertensive encephalopathy, stroke, and cerebral infarction.
Diagnosis
The diagnosis of pheochromocytoma involves a combination of clinical evaluation, laboratory testing, and imaging studies. Key diagnostic tests include:
- Measurement of plasma and urinary catecholamines and their metabolites ( metanephrines)
- CT scan and MRI to localize the tumor
- Functional imaging such as MIBG scintigraphy
Treatment
The primary treatment for pheochromocytoma is surgical removal of the tumor ( adrenal ectomy ). Prior to surgery, patients are treated with alpha and beta blockers to control hypertension and prevent hypertensive crises during the operation. [3] In cases of hypertensive emergencies, intravenous medications such as nitroprusside or nicardipine may be used.
Prognosis and Follow-up
The majority of patients with pheochromocytoma are cured after surgical removal of the tumor. However, long-term follow-up is essential as the tumor may recur in some cases. Patients require regular monitoring of blood pressure, catecholamine levels, and imaging studies to detect any recurrence or metastatic disease.
Conclusion
Pheochromocytoma is a rare but important cause of secondary hypertension. Early recognition and prompt treatment are crucial to prevent potentially life-threatening complications. A multidisciplinary approach involving endocrinologists, surgeons, and radiologists is essential for optimal management of patients with pheochromocytoma.
References
- Pheochromocytoma: An Adrenal Incidentaloma?
- Plasma Norepinephrine in Pheochromocytoma
- Preoperative Management of Pheochromocytoma
